Article Information
vol. 11 no. 523
- Received for publication December 2, 2018
- Resubmitted August 23, 2019
- Accepted for publication November 20, 2019
- .
Author Information
- Na Kong1,2,*,
- Wei Tao1,*,†,
- Xiang Ling1,
- Junqing Wang1,
- Yuling Xiao1,
- Sanjun Shi1,
- Xiaoyuan Ji1,3,
- Aram Shajii1,
- Silvia Tian Gan1,4,
- Na Yoon Kim1,
- Dan G. Duda5,
- Tian Xie3,†,
- Omid C. Farokhzad1,6,† and
- Jinjun Shi1,†
- 1Center for Nanomedicine and Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA.
- 2School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310058, China.
- 3Department of Cancer Pharmacology, Holistic Integrative Pharmacy Institutes, College of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.
- 4Department of Biology, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada.
- 5Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
- 6King Abdulaziz University, Jeddah 21589, Saudi Arabia.
- ↵†Corresponding author. Email: wtao{at}bwh.harvard.edu (W.T.); tianxie{at}hznu.edu.cn (T.X.); ofarokhzad{at}bwh.harvard.edu (O.C.F.); jshi{at}bwh.harvard.edu (J.S.)